An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation

Shengze Yu, Amira Alkharusi, Gunnar Norstedt, Torbjörn Gräslund*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation'. Together they form a unique fingerprint.

Agricultural and Biological Sciences

Physics

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology